Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
05/04/2023 13:51
April 5 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS ANNOUNCES FINANCING TO SUPPORT LAUNCH OF ZIMED
PRESERVATIVE FREE (BIMATOPROST 0.03%) AND BOARD UPDATE
* AEQUUS PHARMACEUTICALS INC - ENTERED INTO A LOAN AGREEMENT
TO
RAISE $500,000 TO SUPPORT LAUNCH OF ZIMED
Source text for Eikon: urn:newsml:reuters.com:*:nGNXldTFd
Further company coverage: AQS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange